1. Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes
   Megan Fracol et al, 2017, Annals of Surgical Oncology CrossRef
2. Enhancing the treatment effects of tumor cell purified autogenous heat shock protein 70-peptide complexes on HER-3-overexpressing breast cancer*
   Xia Chen et al, 2021, Oncology and Translational Medicine CrossRef
3. ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications
   Flavia Linguanti et al, 2023, Cancers CrossRef
4. The rs2292239 polymorphism in ERBB3 gene is associated with risk for type 1 diabetes mellitus in a Brazilian population
   Natália Emerim Lemos et al, 2018, Gene CrossRef
5. The rs705708 A allele of the ERBB3 gene is associated with lower prevalence of diabetic retinopathy and arterial hypertension and with improved renal function in type 1 diabetic patients
   Eloísa Toscan Massignam et al, 2022, Microvascular Research CrossRef
6. Gastric carcinoma in canines and humans, a review
   S. Hugen et al, 2017, Veterinary and Comparative Oncology CrossRef
7. Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma
   Keisuke Okuno et al, 2023, Biomedicines CrossRef
8. Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies
   Danesh Hassani et al, 2022, Cancer Chemotherapy and Pharmacology CrossRef
9. γ-Tocotrienol-induced disruption of lipid rafts in human breast cancer cells is associated with a reduction in exosome heregulin content
   Osama A. Alawin et al, 2017, The Journal of Nutritional Biochemistry CrossRef
10. Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3
    Won‐Jun Jang et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
11. The chromosome-scale genome assembly of the yellowtail clownfish Amphiprion clarkii provides insights into the melanic pigmentation of anemonefish
    Billy Moore et al, 2023, G3: Genes, Genomes, Genetics CrossRef
12. Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab
    Andrew B. Nixon et al, 2024, Prostate Cancer and Prostatic Diseases CrossRef
13. NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells
    Liuting Yang et al, 2017, International Journal of Oncology CrossRef